Skip to main content
Year archive

Biotest AG — 2022 filings

All 53 regulatory filings released by Biotest AG (BIO3) in 2022, sourced directly from the official regulator.

53 Filings
2022 Period
2022 filings (53)
Filing Released Lang
Biotest AG: First patient enrolled in phase II clinical trial for treatment of chronic hepatitis B with hyperimmunoglobulins
Regulatory Filings
2022-12-08 English
Biotest AG: Biotest reports sales of Euro 361 million in the first nine months of 2022
Earnings Release 9M 2022
2022-11-14 English
Biotest AG: Biotest receives approval for new intravenous immunoglobulin Yimmugo (IgG Next Generation)
Regulatory Filings
2022-11-14 English
Interim / Quarterly Report 2022
Interim / Quarterly Report 9M 2022
2022-11-14 English
Interim / Quarterly Report 2022
Interim / Quarterly Report 9M 2022
2022-11-14 English
Q3 statement / Q3 financial report 2022
Interim / Quarterly Report Q1 2022
2022-11-14 English
Biotest AG: Biotest reports sales of Euro 361 million in the first nine months of 2022
Earnings Release 9M 2022
2022-11-08 English
Biotest AG: Biotest AG opens 14th plasma collection centre in the Czech Republic
Regulatory Filings
2022-10-13 English
Biotest AG: Biotest AG opens 13th plasma collection centre in the Czech Republic
Regulatory Filings
2022-09-26 English
Biotest AG: Biotest AG opens 12th plasma collection centre in the Czech Republic
Regulatory Filings
2022-09-06 English
Biotest AG: Biotest achieves an improved adjusted EBIT by 9.8% of EUR 32.4 million in the first half of 2022
Earnings Release H1 2022
2022-08-11 English
Halbjahresfinanzbericht nach WpHG zum Geschäftsjahr vom 01.01.2022 bis zum 30.06.2022
Interim / Quarterly Report H1 2022
2022-08-11 German
Investor Presentation 2022
Investor Presentation
2022-08-11 English
Earnings Release 2022
Earnings Release H2 2022
2022-08-11 English
Half-yearly financial report 2022
Interim / Quarterly Report H2 2022
2022-08-11 German
Biotest AG: Biotest increases EBITDA in first half-year by 52% to 8.8 million EUR
Earnings Release H1 2022
2022-07-28 English
Biotest AG: Biotest grants Renate & Hans Schleussner Research Award for the first time
Regulatory Filings
2022-07-25 English
Investor Presentation 2022
Investor Presentation
2022-06-30 English
Investor Presentation 2022
Investor Presentation
2022-06-30 English
Biotest AG: Biotest achieves important milestone in Phase III study in acquired fibrinogen deficiency
Regulatory Filings
2022-06-10 English
Biotest AG: Biotest AG opens 11th plasma collection centre in Czech Republic
Regulatory Filings
2022-06-09 English
Jahresabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
Notice of Dividend Amount
2022-06-08 German
Biotest AG: Biotest AG opens 10th plasma collection centre in Czech Republic
Regulatory Filings
2022-05-24 English
Biotest AG: Dr Bernhard Ehmer new Chairman of the Supervisory Board of Biotest AG
Board/Management Information
2022-05-06 English
Report Publication Announcement 2022
Report Publication Announcement
2022-05-05 English
Biotest AG: Annual General Meeting approves dividend distribution
AGM Information
2022-05-05 English
Biotest AG: Biotest records sales of 115 million in the first quarter of 2022
Earnings Release Q1 2022
2022-05-05 English
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
Report Publication Announcement
2022-05-05 German
Hinweis auf Halbjahresfinanzbericht vom 01.01.2022 bis zum 30.06.2022
Report Publication Announcement
2022-05-05 German
Q1 statement / Q1 financial report 2022
Interim / Quarterly Report Q1 2022
2022-05-05 English
Biotest AG: Biotest Supervisory Board appoints new Management Board member
Board/Management Information
2022-05-02 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-04-29 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-04-29 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-04-27 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-04-27 English
Biotest AG: Grifols acquires majority of voting rights in Biotest
M&A Activity
2022-04-25 English
Biotest AG: Biotest submits marketing authorisation application for IgG Next Generation and signed first licensing agreement
Regulatory Filings
2022-04-07 English
Biotest Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 05.05.2022 in Dreieich mit dem Ziel der europaweiten Verbreitung gema 121 AktG
AGM Information
2022-03-29 German
Biotest AG: Biotest exceeds sales guidance in fiscal year 2021
Earnings Release FY 2021
2022-03-24 English
Remunerations Report 2021
Remuneration Information
2022-03-24 English
Geschäftsbericht 2021
Annual Report FY 2021
2022-03-24 German
Annual financial report 2021
Annual Report FY 2021
2022-03-24 English
Call Transcript 2022
Call Transcript
2022-03-24 English
Call Transcript 2022
Call Transcript
2022-03-24 German
Biotest AG: Biotest AG opens ninth plasma collection centre in Czech Republic
Regulatory Filings
2022-03-10 English
declaration of compliance 2021
Governance Information
2022-03-10 English
Management declaration 2022 (§315d HGB)
Governance Information
2022-03-10 English
Management declaration 2022 (§289f HGB)
Governance Information
2022-03-10 English
Biotest AG: Biotest exceeds Revenue guidance 2021
Earnings Release FY 2021
2022-02-16 English
Biotest AG: Biotest combats climate change through CO2-neutral production
Environmental & Social Information
2022-01-18 English
Biotest AG: Biotest AG opens eighth plasma collection centre in Czech Republic
Regulatory Filings
2022-01-12 English
Declaration of Voting Results & Voting Rights Announcements 2022
Declaration of Voting Results & Voting Rights Announcements
2022-01-10 English
Biotest AG: Grifols, S.A. will hold more than 95,5498 % of the voting rights upon settlement of the takeover offer
M&A Activity
2022-01-07 English